Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Dumont

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Transfusion Science|February 6, 1998
Statistical process validation of leucoreduced blood componentsL J Dumont
Transfusion Science|June 3, 1999
Challenges in QA of leucodepleted blood component and current standard(s). Challenges in quality assurance of leukoreduced componentsL J Dumont
Transfusion|June 1, 1991
Sampling errors and the precision associated with counting very low numbers of white cells in blood componentsL J Dumont
Blood|August 15, 1996
Prevention of transfusion-associated cytomegalovirus infection: defining the method of preparation for leukocyte-reduced blood productsL J Dumont, R Schuyler
Transfusion|June 1, 1997
Microdroplet fluorochromatic assay for the enumeration of white cells (WBCs) in WBC-reduced blood components: validation and application for evaluating newly developed WBC-reduction filtersP Borzini, L J Dumont
Cytometry|December 15, 1996
Enhanced flow cytometric method for counting very low numbers of white cells in platelet productsL J Dumont, D F Dumont
Blood|April 3, 1999
Ex vivo factors affecting contact phase activation in negatively charged medical devicesJ L Renaux, L J Dumont
Vox Sanguinis|October 9, 2002
Making risk statements stickL J Dumont, J P AuBuchon
Transfusion Medicine Reviews|January 30, 1999
Platelet surface P-selectin measurements in platelet preparations: an international collaborative study. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT)L J Dumont, T VandenBroeke, K A Ault
Transfusion|January 1, 1996
Practical guidelines for process validation and process control of white cell-reduced blood components: report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT)L J Dumont, W H Dzik, P Rebulla, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Transfusion Science|February 6, 1998
Statistical process validation of leucoreduced blood componentsL J Dumont
Transfusion Science|June 3, 1999
Challenges in QA of leucodepleted blood component and current standard(s). Challenges in quality assurance of leukoreduced componentsL J Dumont
Transfusion|June 1, 1991
Sampling errors and the precision associated with counting very low numbers of white cells in blood componentsL J Dumont
Blood|August 15, 1996
Prevention of transfusion-associated cytomegalovirus infection: defining the method of preparation for leukocyte-reduced blood productsL J Dumont, R Schuyler
Transfusion|June 1, 1997
Microdroplet fluorochromatic assay for the enumeration of white cells (WBCs) in WBC-reduced blood components: validation and application for evaluating newly developed WBC-reduction filtersP Borzini, L J Dumont
Cytometry|December 15, 1996
Enhanced flow cytometric method for counting very low numbers of white cells in platelet productsL J Dumont, D F Dumont
Blood|April 3, 1999
Ex vivo factors affecting contact phase activation in negatively charged medical devicesJ L Renaux, L J Dumont
Vox Sanguinis|October 9, 2002
Making risk statements stickL J Dumont, J P AuBuchon
Transfusion Medicine Reviews|January 30, 1999
Platelet surface P-selectin measurements in platelet preparations: an international collaborative study. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT)L J Dumont, T VandenBroeke, K A Ault
Transfusion|January 1, 1996
Practical guidelines for process validation and process control of white cell-reduced blood components: report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT)L J Dumont, W H Dzik, P Rebulla, et al.
Pageof 3